254 related articles for article (PubMed ID: 37158958)
1. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
[TBL] [Abstract][Full Text] [Related]
2. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
Cao J; Liang Y; Gu JJ; Huang Y; Wang B
Front Genet; 2022; 13():991162. PubMed ID: 36353118
[No Abstract] [Full Text] [Related]
3. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma.
Wei W; Liu C; Wang M; Jiang W; Wang C; Zhang S
Front Genet; 2022; 13():906496. PubMed ID: 35938009
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation.
Wang T; Zhou Z; Wang X; You L; Li W; Zheng C; Zhang J; Wang L; Kong X; Gao Y; Sun X
Front Genet; 2022; 13():929035. PubMed ID: 36081998
[No Abstract] [Full Text] [Related]
5. Construction and validation of a prognostic signature for mucinous colonic adenocarcinoma based on N7-methylguanosine-related long non-coding RNAs.
Gao Y; Ren J; Chen K; Guan G
J Gastrointest Oncol; 2024 Feb; 15(1):203-219. PubMed ID: 38482248
[TBL] [Abstract][Full Text] [Related]
6. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs.
Dai YY; Gao YP; Chen LX; Liu JS; Zeng C; Zhou JD; Wu HL
Front Genet; 2022; 13():930446. PubMed ID: 36110218
[No Abstract] [Full Text] [Related]
7. N7-methylguanosine-related lncRNAs: Distinction between hot and cold tumors and construction of predictive models in colon adenocarcinoma.
Cheng Z; Wang J; Xu Y; Jiang T; Xue Z; Li S; Zhao Y; Song H; Song J
Front Oncol; 2022; 12():951452. PubMed ID: 36185235
[TBL] [Abstract][Full Text] [Related]
8. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
[TBL] [Abstract][Full Text] [Related]
9. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer.
Zhao B; Fang F; Liao Y; Chen Y; Wang F; Ma Y; Wei C; Zhao J; Ji H; Wang D; Tang D
BMC Bioinformatics; 2023 Mar; 24(1):100. PubMed ID: 36935487
[TBL] [Abstract][Full Text] [Related]
10. A potential biological signature of 7-methylguanosine-related lncRNA to predict the immunotherapy effects in bladder cancer.
Xie S; He J; Feng B; Rao D; Wang S; He Y
Heliyon; 2023 May; 9(5):e15897. PubMed ID: 37215925
[TBL] [Abstract][Full Text] [Related]
11. Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung Adenocarcinoma.
Zhang C; Zhou D; Wang Z; Ju Z; He J; Zhao G; Wang R
Front Genet; 2022; 13():907754. PubMed ID: 35754819
[TBL] [Abstract][Full Text] [Related]
12. Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma.
Li Y; Zhao K; Wu R; Wang J; Wang Q; Xiong Q; Xie F; Lei H; Feng P
J Gastrointest Oncol; 2023 Jun; 14(3):1392-1411. PubMed ID: 37435203
[TBL] [Abstract][Full Text] [Related]
13. N7-Methylguanosine-Related lncRNAs: Integrated Analysis Associated With Prognosis and Progression in Clear Cell Renal Cell Carcinoma.
Ming J; Wang C
Front Genet; 2022; 13():871899. PubMed ID: 35495133
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification.
Yang C; Zhang L; Hao X; Tang M; Zhou B; Hou J
Curr Oncol; 2022 Dec; 30(1):430-448. PubMed ID: 36661684
[TBL] [Abstract][Full Text] [Related]
15. Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer.
Dai D; Zhuang H; Shu M; Chen L; Long C; Wu H; Chen B
Heliyon; 2024 Apr; 10(8):e29326. PubMed ID: 38628712
[TBL] [Abstract][Full Text] [Related]
16. An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer.
Li Z; Zhao J; Huang X; Wang J
Sci Rep; 2023 Mar; 13(1):4302. PubMed ID: 36922569
[TBL] [Abstract][Full Text] [Related]
17. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
Zhong S; Chen S; Lin H; Luo Y; He J
BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
[TBL] [Abstract][Full Text] [Related]
18. A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma.
Yang S; Zhou J; Chen Z; Sun Q; Zhang D; Feng Y; Wang X; Sun Y
Front Oncol; 2022; 12():934928. PubMed ID: 35992788
[TBL] [Abstract][Full Text] [Related]
19. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers.
He CM; Zhang XD; Zhu SX; Zheng JJ; Wang YM; Wang Q; Yin H; Fu YJ; Xue S; Tang J; Zhao XJ
Front Genet; 2022; 13():998147. PubMed ID: 36226166
[No Abstract] [Full Text] [Related]
20. The Risk Correlation between N7-Methylguanosine Modification-Related lncRNAs and Survival Prognosis of Oral Squamous Cell Carcinoma Based on Comprehensive Bioinformatics Analysis.
Xu Y; Zou X; Mei J
Appl Bionics Biomech; 2022; 2022():1666792. PubMed ID: 36060561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]